Allen & Overy advises the lenders on the acquisition of Haemotronic by GVS
Related people
Headlines in this article
Related news and insights
News: 21 March 2024
Allen & Overy advises on EUR500 million Senior Non-Preferred dematerialised bond by Mediobanca
News: 14 March 2024
Allen & Overy advises on EUR300 million bond and liability management by Banca Popolare di Sondrio
News: 13 March 2024
Allen & Overy advises FinecoBank on a new Additional Tier 1 bond and a liability management deal
News: 12 March 2024
Allen & Overy advises on the acquisition of an NPL portfolio
Allen & Overy has advised a pool of lending banks on financing for the acquisition of the Haemotronic Group by GVS S.p.A.
GVS, a leading supplier of advanced filtration solutions for highly critical applications, is acquiring Haemontronic, specialised producer of components and bags for the medical sector - with plants in Italy and Mexico - from M.E.R.A. Holding S.p.A., company controlled by Matteo Ravizza.
In order to finance the operation, GVS will sign a fie-year loan agreement for a total of EUR230 million with a pool of lending banks, including Mediobanca - Banca di Credito Finanziario S.p.A., and Unicredit S.p.A, which act, inter alia, as global coordinators and bookrunners.
A&O advised on the deal with a team led by partner Pietro Scarfone and senior associate Luca Maffia with support of associate Arnaldo Mitola. A team comprising counsel Elia Ferdinando Clarizia and associate Lino Ziliotti advised on tax aspects.